These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 15604991)

  • 1. Evaluation of sensitivity to 5-FU on the basis of thymidylate synthase (TS)/dihydropyrimidine dehydrogenase (DPD) activity and chromosomal analysis in micro tissue specimens of breast cancer.
    Ota D; Kusama M; Kaise H; Nakayama S; Misaka T; Tsuchida A; Aoki T
    Breast Cancer; 2004; 11(4):356-66. PubMed ID: 15604991
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dihydropyrimidine dehydrogenase and messenger RNA levels in gastric cancer: possible predictor for sensitivity to 5-fluorouracil.
    Ishikawa Y; Kubota T; Otani Y; Watanabe M; Teramoto T; Kumai K; Takechi T; Okabe H; Fukushima M; Kitajima M
    Jpn J Cancer Res; 2000 Jan; 91(1):105-12. PubMed ID: 10744051
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thymidylate synthase and dihydropyrimidine dehydrogenase gene expression in breast cancer predicts 5-FU sensitivity by a histocultural drug sensitivity test.
    Kakimoto M; Uetake H; Osanai T; Shirota Y; Takagi Y; Takeshita E; Toriya Y; Danenberg K; Danenberg PV; Sugihara K
    Cancer Lett; 2005 Jun; 223(1):103-11. PubMed ID: 15890242
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thymidylate synthetase (TS) genotype and TS/dihydropyrimidine dehydrogenase mRNA level as an indicator in determining chemosensitivity to 5-fluorouracil in advanced gastric carcinoma.
    Toriumi F; Kubota T; Saikawa Y; Yoshida M; Otani Y; Watanabe M; Kumai K; Kitajima M
    Anticancer Res; 2004; 24(4):2455-63. PubMed ID: 15330198
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thymidylate synthase and dihydropyrimidine dehydrogenase mRNA levels in thymoma.
    Sasaki H; Fukai I; Kiriyama M; Kaji M; Yano M; Yamakawa Y; Fujii Y
    Surg Today; 2003; 33(2):83-8. PubMed ID: 12616366
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TS and DPD mRNA levels on formalin-fixed paraffin-embedded specimens as predictors for distant recurrence of rectal cancer treated with preoperative chemoradiotherapy.
    Tanaka K; Saigusa S; Toiyama Y; Koike Y; Okugawa Y; Yokoe T; Inoue Y; Kobayashi M; Miki C; Kusunoki M
    J Surg Oncol; 2012 May; 105(6):529-34. PubMed ID: 22006578
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictive role of thymidylate synthase, dihydropyrimidine dehydrogenase and thymidine phosphorylase expression in colorectal cancer patients receiving adjuvant 5-fluorouracil.
    Ciaparrone M; Quirino M; Schinzari G; Zannoni G; Corsi DC; Vecchio FM; Cassano A; La Torre G; Barone C
    Oncology; 2006; 70(5):366-77. PubMed ID: 17179731
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dihydropyrimidine dehydrogenase activity and thymidylate synthase level are associated with response to 5-fluorouracil in human colorectal cancer.
    Araki Y; Isomoto H; Shirouzu K
    Kurume Med J; 2001; 48(2):93-8. PubMed ID: 11501504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thymidylate synthase and dihydropyrimidine dehydrogenase mRNA expression levels: predictors for survival in colorectal cancer patients receiving adjuvant 5-fluorouracil.
    Kornmann M; Schwabe W; Sander S; Kron M; Sträter J; Polat S; Kettner E; Weiser HF; Baumann W; Schramm H; Häusler P; Ott K; Behnke D; Staib L; Beger HG; Link KH
    Clin Cancer Res; 2003 Sep; 9(11):4116-24. PubMed ID: 14519634
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dihydropyrimidine dehydrogenase and thymidylate synthase activities in hepatocellular carcinomas and in diseased livers.
    Baba H; Teramoto K; Kawamura T; Mori A; Imamura M; Arii S
    Cancer Chemother Pharmacol; 2003 Dec; 52(6):469-76. PubMed ID: 13680162
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discrepancies between the gene expression, protein expression, and enzymatic activity of thymidylate synthase and dihydropyrimidine dehydrogenase in human gastrointestinal cancers and adjacent normal mucosa.
    Miyamoto S; Ochiai A; Boku N; Ohtsu A; Tahara M; Yoshida S; Okabe H; Takechi T; Fukushima M
    Int J Oncol; 2001 Apr; 18(4):705-13. PubMed ID: 11251164
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High expression of dihydropyrimidine dehydrogenase in lung adenocarcinoma is associated with mutations in epidermal growth factor receptor: implications for the treatment of non--small-cell lung cancer using 5-fluorouracil.
    Mochinaga K; Tsuchiya T; Nagasaki T; Arai J; Tominaga T; Yamasaki N; Matsumoto K; Miyazaki T; Nanashima A; Hayashi T; Tsukamoto K; Nagayasu T
    Clin Lung Cancer; 2014 Mar; 15(2):136-144.e4. PubMed ID: 24405586
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative measurement of thymidylate synthase and dihydropyrimidine dehydrogenase mRNA level in gastric cancer by real-time RT-PCR.
    Fujiwara H; Terashima M; Irinoda T; Takagane A; Abe K; Kashiwaba M; Oyama K; Takahashi M; Maesawa C; Saito K; Takechi T; Fukushima M
    Jpn J Cancer Res; 2002 Dec; 93(12):1342-50. PubMed ID: 12495474
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dihydropyrimidine dehydrogenase mRNA level correlates with the response to 5-fluorouracil-based chemo-immuno-radiation therapy in human oral squamous cell cancer.
    Hoque MO; Kawamata H; Nakashiro KI; Omotehara F; Shinagawa Y; Hino S; Begum NM; Uchida D; Yoshida H; Sato M; Fujimori T
    Int J Oncol; 2001 Nov; 19(5):953-8. PubMed ID: 11604993
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dihydropyrimidine dehydrogenase activity and messenger RNA level may be related to the antitumor effect of 5-fluorouracil on human tumor xenografts in nude mice.
    Ishikawa Y; Kubota T; Otani Y; Watanabe M; Teramoto T; Kumai K; Kitajima M; Takechi T; Okabe H; Fukushima M
    Clin Cancer Res; 1999 Apr; 5(4):883-9. PubMed ID: 10213225
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prediction of sensitivity to fluoropyrimidines by metabolic and target enzyme activities in gastric cancer.
    Terashima M; Fujiwara H; Takagane A; Abe K; Irinoda T; Nakaya T; Yonezawa H; Oyama K; Saito K; Kanzaki N; Ohtani S; Nemoto T; Hoshino Y; Kogure M; Gotoh M
    Gastric Cancer; 2003; 6 Suppl 1():71-81. PubMed ID: 12775024
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low thymidylate synthase, thymidine phosphorylase, and dihydropyrimidine dehydrogenase mRNA expression correlate with prolonged survival in resected non-small-cell lung cancer.
    Grimminger PP; Schneider PM; Metzger R; Vallböhmer D; Hölscher AH; Danenberg PV; Brabender J
    Clin Lung Cancer; 2010 Sep; 11(5):328-34. PubMed ID: 20837458
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thymidylate synthase, dihydropyrimidine dehydrogenase and thymidine phosphorylase expression in colorectal cancer and normal mucosa in patients.
    Amatori F; Di Paolo A; Del Tacca M; Fontanini G; Vannozzi F; Boldrini L; Bocci G; Lastella M; Danesi R
    Pharmacogenet Genomics; 2006 Nov; 16(11):809-16. PubMed ID: 17047489
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thymidylate synthase, thymidine phosphorylase, dihydropyrimidine dehydrogenase expression, and histological tumour regression after 5-FU-based neo-adjuvant chemoradiotherapy in rectal cancer.
    Jakob C; Aust DE; Meyer W; Baretton GB; Schwabe W; Häusler P; Becker H; Liersch T
    J Pathol; 2004 Dec; 204(5):562-8. PubMed ID: 15538739
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlations between expression levels of thymidylate synthase, thymidine phosphorylase and dihydropyrimidine dehydrogenase, and efficacy of 5-fluorouracil-based chemotherapy for advanced colorectal cancer.
    Bai W; Wu Y; Zhang P; Xi Y
    Int J Clin Exp Pathol; 2015; 8(10):12333-45. PubMed ID: 26722420
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.